Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2026CureusOpen Access

Transscleral Micropulse Cyclophotocoagulation for the Treatment of Refractory Primary Congenital Glaucoma: A Case Series

View Full Paper
Ask AI
Bookmark
Share

Authors

SHShuji HiranoHIHidekazu InamiTITaiga Inooka

Discussion

Loading...

Member takes

Overview

Case series demonstrates initial IOP reduction in refractory childhood glaucoma, suggesting limited effectiveness.

Key Points

  • To evaluate the safety and efficacy of transscleral micropulse cyclophotocoagulation (MPCPC) in treating refractory primary congenital glaucoma.
  • Case series of four patients with refractory primary congenital glaucoma
  • All procedures performed under general anesthesia
  • Initial and follow-up intraocular pressure (IOP) measurements after MPCPC
  • Transient reduction of IOP observed in all patients after MPCPC
  • IOP rose again within three months for all cases
  • No vision-threatening complications reported

Cite This Study

Hirano et al. (2026) studied this question.

synapsesocial.com/papers/69df2a4be4eeef8a2a6af8fdhttps://doi.org/10.7759/cureus.106914
View Full Paper
Ask AI
Bookmark
Share